Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Aerospace & Defense
Employment
Science
Infectious Disease
Freight & Air Courrier
Obesity, Weight Control & Nutrition
Gerontology
Oil & Gas
Computer Apps, Software & OS
Table bottom

Dermatology
Array BioPharma Inc. (Nasdaq: ARRY) and Pierre Fabre today announced updated results from the 30 patient safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK...
PR Newswire, 10:13am ET



1-1 of 1


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.